Fertility and pregnancy
What human research has studied for conception, pregnancy outcomes and lactation, across every ingredient in this guide, strongest evidence first. A grade describes the evidence, not a recommendation.
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. Ask a doctor or pharmacist before use, especially with medicines, in pregnancy or for a child.
How strong the evidence is
Where fertility and pregnancy sits on the supplement body map; colored by its strongest grade here.
Findings by ingredient
| Ingredient | Grade | What was studied and found |
|---|---|---|
| Folate (folic acid) | A | Neural tube defects (periconceptional use). Clinical trials show adequate periconceptional folic acid reduces a substantial share of neural tube defects; US rates fell 28% after 1998 fortification. USPSTF recommends 400 to 800 mcg starting at least 1 month before conception. sources |
| Iron | A | Anemia and iron deficiency in pregnancy. A 2015 Cochrane review found daily iron supplementation in pregnancy reduced maternal anemia at term by 70% and iron deficiency at term by 57%; low birthweight was 8.4% versus 10.3%, a difference that was not statistically clear (RR 0.84, 95% CI 0.69 to 1.03). sources |
| Multivitamin/mineral supplements | A | Birth outcomes (supplements in pregnancy). A 2019 Cochrane review (20 trials, 141,849 women) found multiple-micronutrient supplements reduced low birthweight versus iron with or without folic acid (RR 0.88, 95% CI 0.85 to 0.91) and probably slightly reduced preterm birth (RR 0.95, 0.90 to 1.01). sources |
| Calcium | B | Preeclampsia in pregnancy. A Cochrane review (27 RCTs, 18,064 women) reported fewer cases with at least 1,000 mg/day, mainly in women with low calcium intake; evidence quality was low and large trials were not significant. sources |
| L-carnitine | B | Sperm quality and fertility in men. A 2022 Cochrane review (6 trials, 1,089 men) found improved sperm motility and concentration at some time points, but no effect on live birth or pregnancy rates. sources |
| Lactoferrin | B | Iron deficiency anemia in pregnancy (compared with ferrous sulfate). A 2017 meta-analysis of 4 RCTs (600 pregnant women) found hemoglobin rose more at 4 weeks with daily oral bovine lactoferrin than with ferrous sulfate (mean difference 0.77), with fewer gastrointestinal side effects. sources |
| Moringa | B | Breast-milk supply. LactMed cites a meta-analysis (14 studies, 865 subjects) indicating increased serum prolactin and milk volume; other pooled analyses combined small studies, some with methodologic problems. Long-term benefit to infants is not well studied. sources |
| Myo-inositol | B | Gestational diabetes and other pregnancy outcomes. A Cochrane review of 7 trials (1,319 pregnant women; 6 in Italy) found myo-inositol may reduce gestational diabetes (RR 0.53) and hypertensive disorders of pregnancy; certainty was low to very low. sources |
| Omega-3 fatty acids | B | Preterm birth (supplements in pregnancy). A 2018 Cochrane review (70 RCTs, 19,927 women) reported 11% lower risk of birth before 37 weeks; a 2016 AHRQ review found pregnancies lasted slightly longer but no effect on risk of premature birth. sources |
| Shatavari | B | Breast-milk supply after childbirth. LactMed describes clinical results as mixed, often with herbal mixtures; one small well-done trial found greater prolactin and infant weight gain than placebo, while a 4-week trial of a shatavari mixture (64 women) found no difference. sources |
| Ashwagandha | C | Testosterone and sperm quality in men. NCCIH describes some limited evidence that 2 to 4 months of use may increase testosterone levels and sperm quality. sources |
| Chasteberry (vitex) | C | Infertility and sexual dysfunction. There isn't enough reliable evidence to know whether chasteberry helps; it may be unsafe during pregnancy. sources |
| Choline | C | Neural tube defects. Some evidence links lower maternal blood choline to higher neural tube defect risk; other research found no such relationship. sources |
| Cumin | C | Breast-milk supply. LactMed: cumin has been used as a galactogogue with some literature support, including in herbal mixtures; no data exist on its safety in nursing mothers or infants. sources |
| Evening primrose oil | C | Starting labor. Studies of oral and vaginal use to help start labor have had inconsistent results. sources |
| Fennel | C | Breast-milk supply. LactMed: two small studies found increases in some measures such as milk volume, fat content and infant weight gain; no increase in serum prolactin has been found. sources |
| Fenugreek | C | Breast milk supply. Cochrane 2020 (41 galactagogue trials): fenugreek was among natural products studied; milk-volume results could not be pooled, and evidence for fenugreek or fennel on infant weight was very low certainty. sources |
| Iodine | C | Child development after supplementation in pregnancy. Lower maternal iodine status was linked to lower child verbal IQ in a meta-analysis, but two trials of 150–200 mcg/day in pregnancy found no effect on child cognitive, language or motor scores. sources |
| Maca | C | Semen quality. A 2022 meta-analysis of five randomized trials found mixed effects and no significant increase in sperm concentration versus placebo in men with infertility. sources |
| Milk thistle | C | Breast milk production. NCCIH states the effect is unclear. sources |
| Myo-inositol | C | Live birth and pregnancy in subfertile women with PCOS. A Cochrane review of 13 trials (1,472 women, mostly before IVF) found very low-quality evidence; it is uncertain whether myo-inositol improves live birth or clinical pregnancy rates. sources |
| Shatavari | C | Milk volume in the first 72 hours after delivery. A randomized, double-blind trial (113 women analyzed, 300 mg root extract twice daily for 72 hours) reported higher milk volume and earlier breast fullness than placebo; no adverse events occurred. sources |
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.